X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4062) 4062
Publication (526) 526
Book Review (387) 387
Newsletter (75) 75
Conference Proceeding (12) 12
Magazine Article (8) 8
Book Chapter (7) 7
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3401) 3401
minocycline - pharmacology (2333) 2333
humans (2051) 2051
minocycline (1790) 1790
animals (1449) 1449
anti-bacterial agents - pharmacology (1396) 1396
pharmacology & pharmacy (1339) 1339
male (1185) 1185
minocycline - analogs & derivatives (1097) 1097
microbiology (970) 970
microbial sensitivity tests (919) 919
minocycline - therapeutic use (893) 893
female (735) 735
infectious diseases (641) 641
mice (625) 625
rats (589) 589
neurosciences (570) 570
anti-bacterial agents - therapeutic use (561) 561
tigecycline (507) 507
antibiotics (456) 456
adult (405) 405
disease models, animal (396) 396
minocycline - administration & dosage (382) 382
middle aged (361) 361
microglia (341) 341
infections (338) 338
analysis (295) 295
inflammation (293) 293
microglia - drug effects (288) 288
rats, sprague-dawley (277) 277
susceptibility (268) 268
time factors (256) 256
tetracyclines (248) 248
research (244) 244
aged (243) 243
drug resistance, bacterial (240) 240
bacteria (239) 239
treatment outcome (235) 235
drug resistance, multiple, bacterial (232) 232
in-vitro (231) 231
dose-response relationship, drug (230) 230
tetracycline - pharmacology (230) 230
neuroprotective agents - pharmacology (223) 223
anti-bacterial agents - administration & dosage (221) 221
doxycycline (221) 221
expression (221) 221
tetracycline (220) 220
acinetobacter baumannii - drug effects (217) 217
cells, cultured (215) 215
minocycline - adverse effects (213) 213
immunology (210) 210
activation (209) 209
brain (204) 204
health aspects (201) 201
tetracyclines - pharmacology (201) 201
drug resistance (196) 196
resistance (194) 194
doxycycline - pharmacology (192) 192
microglial activation (190) 190
rats, wistar (185) 185
drug therapy (183) 183
drug therapy, combination (183) 183
infectious disease (181) 181
mouse model (179) 179
neurology (179) 179
pharmacology (178) 178
microglia - metabolism (177) 177
article (176) 176
apoptosis (173) 173
mice, inbred c57bl (168) 168
efficacy (166) 166
staphylococcus aureus - drug effects (162) 162
therapy (162) 162
minocycline - pharmacokinetics (159) 159
anti-bacterial agents - adverse effects (158) 158
biochemistry & molecular biology (156) 156
clinical neurology (156) 156
gar-936 (156) 156
neuroprotection (155) 155
adolescent (152) 152
oxidative stress (152) 152
pneumonia (152) 152
oncology (148) 148
care and treatment (147) 147
glycylcycline (141) 141
neurons (141) 141
klebsiella pneumoniae - drug effects (138) 138
rodents (138) 138
antimicrobial agents (137) 137
drug synergism (135) 135
medicine & public health (134) 134
neurons - drug effects (134) 134
gram-negative bacteria - drug effects (133) 133
acinetobacter infections - microbiology (130) 130
pharmacokinetics (130) 130
in-vitro activity (129) 129
model (128) 128
abridged index medicus (126) 126
infection (125) 125
biochemical phenomena, metabolism, and nutrition (124) 124
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3933) 3933
Japanese (92) 92
French (38) 38
Chinese (22) 22
Spanish (20) 20
German (17) 17
Turkish (10) 10
Italian (6) 6
Russian (5) 5
Dutch (3) 3
Polish (3) 3
Czech (2) 2
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2014, Volume 58, Issue 3, pp. 1757 - 1762
Journal Article
中华医学杂志:英文版, ISSN 0366-6999, 2017, Volume 130, Issue 6, pp. 659 - 664
Journal Article
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 6/2019, Volume 145, Issue 6, pp. 1495 - 1507
Constructed from a theoretical framework, the coordinated undermining of survival paths in glioblastoma (GBM) is a combination of nine drugs approved for... 
CUSP9 | Medicine & Public Health | Hematology | Glioblastoma | Repurposed drugs | Oncology | Cancer Research | Internal Medicine | Glioblastoma stem cells | Temozolomide | TARGETED THERAPY | INITIATING CELLS | INTRATUMORAL HETEROGENEITY | PHARMACODYNAMICS | CLINICAL PHARMACOKINETICS | ADJUVANT TEMOZOLOMIDE | MALIGNANT GLIOMA | DISULFIRAM | IN-VITRO | ONCOLOGY | ADULT HUMAN BRAIN | Celecoxib - administration & dosage | Captopril - pharmacology | Aprepitant - administration & dosage | Minocycline - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Brain Neoplasms - pathology | Temozolomide - pharmacology | Brain Neoplasms - metabolism | Itraconazole - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Auranofin - administration & dosage | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Glioblastoma - metabolism | Itraconazole - administration & dosage | Minocycline - administration & dosage | Tumor Cells, Cultured | Quetiapine Fumarate - pharmacology | Aprepitant - pharmacology | Auranofin - pharmacology | Reproducibility of Results | Sertraline - pharmacology | Celecoxib - pharmacology | Brain Neoplasms - drug therapy | Mice, SCID | Xenograft Model Antitumor Assays | Captopril - administration & dosage | Quetiapine Fumarate - administration & dosage | Animals | Sertraline - administration & dosage | Signal Transduction - drug effects | Temozolomide - administration & dosage | Glioblastoma - pathology | Mice | Glioblastoma - drug therapy | Disulfiram - pharmacology | Disulfiram - administration & dosage | Drug Screening Assays, Antitumor | Original – Cancer Research
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 08/2005, Volume 94, Issue 3, pp. 819 - 827
Minocycline is neuroprotective in animal models of a number of acute CNS injuries and neurodegenerative diseases. While anti‐inflammatory and anti‐apoptotic... 
neurodegenerative diseases | lipid peroxidation assay | deoxyribose degradation assay | radical scavenging assay | tetracyclines | mixed neuronal cultures | Deoxyribose degradation assay | Mixed neuronal cultures | Radical scavenging assay | Neurodegenerative diseases | Tetracyclines | Lipid peroxidation assay | CEREBELLAR GRANULE NEURONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROTOXICITY | NEUROSCIENCES | neuroclegenerative diseases | CELL-DEATH | IN-VITRO | CORTICAL-NEURONS | MOUSE MODEL | DISEASE | SPINAL-CORD-INJURY | CYTOCHROME-C RELEASE | Free Radical Scavengers - pharmacology | L-Lactate Dehydrogenase - metabolism | Embryo, Mammalian | Minocycline - pharmacology | Antipyrine - pharmacology | Minocycline - chemistry | Oxidative Stress - physiology | Cerebral Cortex - cytology | Deoxyribose - metabolism | Dose-Response Relationship, Drug | Drug Interactions | Neuroprotective Agents - pharmacology | Antipyrine - analogs & derivatives | Chromans - pharmacology | Lipid Peroxidation - drug effects | Inhibitory Concentration 50 | Cell Death - drug effects | Neurons - drug effects | Glutamic Acid - pharmacology | Cells, Cultured | Phenethylamines - metabolism | Rats | Antioxidants - pharmacology | Rats, Sprague-Dawley | Sulfonic Acids - metabolism | Animals | Free Radicals - pharmacology | Oxidative Stress - drug effects | Dizocilpine Maleate - pharmacology | Benzothiazoles | Vitamin E - pharmacology | Antioxidants | Oxidation | Antibiotics | Neurons | Stress | Index Medicus
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2018, Volume 141, pp. 201 - 213
Given our recent evidence for the role of high mobility group box 1 (HMGB1) in chemotherapy-induced peripheral neuropathy (CIPN) in rats, we examined the... 
Chemotherapy-induced peripheral neuropathy | Paclitaxel | Reactive oxygen species (ROS) | High mobility group box 1 (HMGB1) | Macrophage | CELLS | OXIDATIVE STRESS | SOLUBLE THROMBOMODULIN | RAT | ROOT GANGLION NEURONS | ALLODYNIA | NEUROSCIENCES | CHEMOTHERAPY | PHARMACOLOGY & PHARMACY | NF-KAPPA-B | EXPRESSION | HYPERSENSITIVITY | Hyperalgesia - chemically induced | Peripheral Nervous System Diseases - chemically induced | Pyruvates - pharmacology | Reactive Oxygen Species - metabolism | Clodronic Acid - pharmacology | Minocycline - pharmacology | Coculture Techniques | Male | Phosphoproteins - metabolism | Paclitaxel - antagonists & inhibitors | Thrombomodulin - metabolism | Thiocarbamates - pharmacology | HMGB1 Protein - metabolism | Proline - pharmacology | Membrane Proteins - metabolism | Neurons - metabolism | Sciatic Nerve - drug effects | Phosphorylation - drug effects | Peripheral Nervous System Diseases - complications | Peripheral Nervous System Diseases - immunology | Recombinant Proteins - metabolism | Proline - analogs & derivatives | Hyperalgesia - complications | Receptor for Advanced Glycation End Products - metabolism | Cells, Cultured | Hyperalgesia - prevention & control | Paclitaxel - adverse effects | Imidazoles - pharmacology | Antibodies - pharmacology | Up-Regulation - drug effects | p300-CBP Transcription Factors - metabolism | Macrophages - metabolism | Animals | Acetylcysteine - pharmacology | Macrophages - drug effects | Mice | Pyridines - pharmacology | Receptors, CXCR4 | Ganglia, Spinal - metabolism | Chemotherapy | Cysteine | Chromosomal proteins | Macrophages | Cancer | Cystine | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2006, Volume 50, Issue 5, pp. 1865 - 1868
Journal Article